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Background: Chronic heart failure is a very common condition in the elderly, characterized 
not only by high mortality rates, but also by a strong impact on health-related quality of life 
(HRQOL). Previous studies of HRQOL in elderly heart failure subjects have included mostly 
outpatients, and little is known about determinants of HRQOL in hospitalized elderly popula-
tion, especially in Serbia. In this study, we tried to identify factors that influence HRQOL in 
elderly patients hospitalized with chronic heart failure in Serbia.
Methods: The study population consisted of 136 patients aged 65 years or older hospitalized 
for chronic heart failure. HRQOL was assessed using the Minnesota Living with Heart Failure 
questionnaire. Predictors of HRQOL were identified by multiple linear regression analysis.
Results: Univariate analysis showed that patients with lower income, a longer history of chronic 
heart failure, and longer length of hospital stay, as well as those receiving aldosterone antago-
nists and digoxin, taking multiple medications, in a higher NYHA class, and showing signs of 
depression and cognitive impairment had significantly worse HRQOL. Presence of depressive 
symptoms (P,0.001), higher NYHA class (P=0.021), lower income (P=0.029), and longer 
duration of heart failure (P=0.049) were independent predictors of poor HRQOL.
Conclusion: Depressive symptoms, higher NYHA class, lower income, and longer duration 
of chronic heart failure are independent predictors of poor HRQOL in elderly patients hospi-
talized with chronic heart failure in Serbia. Further, there is an association between multiple 
medication usage and poor HRQOL, as well as a negative impact of cognitive impairment on 
HRQOL. Hence, measures should be implemented to identify such patients, especially those 
with depressive symptoms, and appropriate interventions undertaken in order to improve their 
HRQOL.
Keywords: elderly, heart disease, self-perception of health, depression
Introduction
Chronic heart failure (CHF) is a very common condition in the aged population, with 
a prevalence of up to 12%.1 It is characterized by high mortality, which reaches 50% 
in the 5 years following diagnosis.2 No less importantly, CHF affects daily functioning 
in elderly patients, ultimately impairing their health-related quality of life (HRQOL).3 
HRQOL is defined as the patient’s subjective perception of the influence of disease on 
their everyday life.4 In patients with CHF, HRQOL may be impaired by symptoms of 
the disease (dyspnea, fatigue), psychologic disorders (anxiety, depression), adverse 
effects of drugs, and costs of treatment.4–8
Previous studies have shown that HRQOL in CHF patients is predominantly influ-
enced by New York Heart Association (NYHA) class, indicating that those with higher 
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NYHA class have poorer HRQOL.3–6,9–12 Although left ven-
tricular ejection fraction (LVEF) is an important predictor of 
survival in CHF patients, data from the literature suggest that 
HRQOL is equally impaired in patients with preserved and 
reduced LVEF.5,11,13 In addition, earlier studies have identified 
advanced age, female sex, depression, and treatment with 
aldosterone antagonists as factors having a negative influ-
ence on HRQOL in CHF patients,7–10,14 while improvement of 
HRQOL was noted in subjects taking angiotensin-converting 
enzyme inhibitors and beta-blockers.15
Previous studies on HRQOL in elderly CHF patients 
have included mostly outpatients,3,9,10,16–21 so little is known 
about determinants of HRQOL in the hospitalized elderly 
population,22–26 especially in Serbia, where only one paper 
(that covered a younger population) has been published so 
far.27 In addition, studies performed in hospitalized elderly 
patients with CHF have paid little or no attention to the 
effects that multiple medication usage, depression, and cog-
nitive impairment, which are very common among elderly 
patients, have on HRQOL. Accordingly, in this study we 
tried to identify demographic and clinical variables, includ-
ing depression, cognitive status, and medication usage, that 
influence HRQOL in elderly patients hospitalized with CHF 
in Serbia.
Patients and methods
study population and design
The study population consisted of 136 consecutive elderly 
patients hospitalized for CHF at the geriatric department of 
Zvezdara University Hospital in Belgrade, Serbia, between 
February 2009 and October 2011. Inclusion criteria were 
age $65 years and an established diagnosis of CHF. 
 Exclusion criteria were cancer in the terminal phase, end-
stage renal failure, previous stroke with immobility, and 
severe dementia. Diagnosis of CHF was made according to 
the guidelines for the diagnosis and treatment of CHF from 
the European Society of Cardiology.28
sociodemographic and clinical 
characteristics
Patients were interviewed in order to obtain sociodemo-
graphic data, ie, age, sex, marital status, educational level, 
and household information, such as number of household 
members and income. Clinical data collected from the medi-
cal history included duration of CHF, length of hospital stay, 
history of previous myocardial infarction, angina, hyperten-
sion, and diabetes, as well as current medication. NYHA 
class was determined for each patient according to their 
symptoms. LVEF was assessed by echocardiography using 
the modified Simpson’s rule.
health-related quality of life
HRQOL was assessed using the Serbian version of the 
 Minnesota Living with Heart Failure Questionnaire 
(MLHFQ), which is one of the most commonly used disease-
specific instruments for measuring HRQOL in heart failure, 
with proven reliability and validity.29,30 The questionnaire 
consists of 21 items asking how much the disease and its 
treatment have affected the patient’s life in the previous 
month. Available responses for each question range from 
0 (no effect) to 5 (very much). The total score is calculated 
by adding ratings from all 21 items and can range from 0 to 
105 points, with higher scores indicating poorer HRQOL. In 
addition to total score, MLHFQ measures the physical (eight 
items; range 0–40) and emotional (five items; range 0–25) 
dimensions of HRQOL.
Depressive symptoms and cognitive 
status
The presence of depressive symptoms was assessed by the 
five-item Geriatric Depression Scale.31 Total score can range 
from 0 to 5, with a result $2 points indicating possible 
depression. The presence of cognitive impairment was tested 
by the Mini-Mental State Examination, and subjects with 
scores ,25 were considered to be cognitively impaired.32
statistical analysis
Continuous variables are presented as the mean ± standard 
deviation, while categoric data are expressed as the numbers 
and percentage. Differences between independent groups 
were calculated using the Student’s t-test for normally distrib-
uted variables and the Mann-Whitney U test for non-normally 
distributed variables. Correlations were calculated using 
Pearson’s correlation coefficient for linear relationships, and 
with Spearman’s rank correlation coefficient for nonlinear 
relationships between two variables. Factors predictive of 
HRQOL were identified using multiple linear regression 
analysis. The regression model included variables related 
to the MLHFQ score with P,0.10 calculated in univariate 
analysis. All P-values ,0.05 were considered to be statisti-
cally significant.
ethical considerations
All participants gave their written informed consent. The 
study was approved by the local ethics committee and per-
formed in accordance with the Declaration of Helsinki.
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Results
Baseline patient characteristics
The baseline patient characteristics are presented in 
Table 1. The mean patient age was 77.8 years, and males 
comprised the majority. More than two thirds of subjects 
were in NYHA classes III and IV. The mean LVEF was 
40.9%.  Depressive symptoms and cognitive impairment 
were present in more than half of our patients. The mean 
total MLHFQ score was 50.4.
Factors associated with hrQOl
We have presented demographic and clinical characteristics, 
as well as medications and their associations with total, 
physical, and emotional MLHFQ score. Demographic fac-
tors related to HRQOL are shown in Table 2. We found no 
correlation between age and HRQOL, and no significant 
difference between male and female patients regarding 
HRQOL. The educational level of patients correlated posi-
tively with the physical dimension of HRQOL (P=0.038), 
but not with total or emotional MLHFQ score. Household 
income correlated negatively with total (P=0.013) and 
physical score (P=0.012) on the MLHFQ, but not with the 
emotional dimension (P=0.576), indicating that patients with 
higher income had better overall HRQOL and its physical 
 dimension. With regard to number of household members, we 
found an inverse correlation with the emotional dimension 
of HRQOL (P=0.035).
Clinical factors related to HRQOL are shown in 
Table 3. Duration of CHF correlated negatively with 
HRQOL and its physical dimension (P=0.010 and P=0.011, 
 respectively), but not with its emotional dimension 
(P=0.085). We found no difference in HRQOL between 
patients with and without a history of previous myocar-
dial infarction, angina,  hypertension, and diabetes. There 
was no correlation between number of comorbidities and 
MLHFQ scores.
Patients with higher NYHA class (III or IV) had worse 
overall HRQOL, including its physical and emotional dimen-
sions (P,0.001, P,0.001, and P=0.023, respectively). We 
noticed no difference in HRQOL between subjects with 
preserved and reduced LVEF.
Subjects with depressive symptoms had poorer overall 
HRQOL, including its physical and emotional domains, than 
their nondepressive counterparts (P,0.001, P,0.001, and 
P,0.001, respectively). Patients with cognitive impairment 
had worse overall HRQOL and its emotional dimension 
than those with preserved cognitive function (P=0.030 and 
P=0.022, respectively).
Length of hospital stay correlated inversely with overall 
HRQOL and its emotional dimension (P=0.021 and P=0.020, 
respectively).
Current medications and their association with HRQOL 
are presented in Table 4. Patients receiving aldosterone 
antagonists and digoxin had worse HRQOL (P=0.046 and 
P=0.049, respectively). Further, patients on aldosterone 
antagonists had a worse physical dimension of HRQOL 
(P=0.048). We did not perform a statistical analysis on use of 
angiotensin II receptor blockers and HRQOL due to the small 
Table 1 Baseline patient characteristics (n=136)
Characteristic Value
Age (years) 77.8±5.9
Male sex 72 (52.9)
Marital status
 Married 47 (34.6)
 single, divorced, widowed 89 (65.4)
education
 .12 years 27 (19.9)
 #12 years 109 (80.1)
number of household members 2.4±1.4
household income (monthly, Us dollars) 447.2±297.7
Duration of ChF (months) 61.9±71.1
Previous
 Myocardial infarction 44 (32.4)
 Angina 80 (58.8)
hypertension 101 (74.3)
Diabetes mellitus 42 (30.9)
Three or more comorbidities 90 (66.2)
Current medications
 Diuretics 128 (94.1)
 Aldosterone antagonists 67 (49.3)
 ACeIs 104 (76.5)
 ArBs 3 (2.2)
 Beta-blockers 69 (50.7)
 Digoxin 41 (30.1)
 Anticoagulants 51 (37.5)
number of drugs 6.9±2.3
nYhA class
 I 2 (1.5)
 II 36 (26.5)
 III 63 (46.3)
 IV 35 (25.7)
lVeF (%) 40.9±11.0
Depressive symptoms 76 (55.9)
Cognitive impairment 71 (52.2)
length of hospital stay (days) 18.0±9.5
MlhFQ score
 Total 50.4±19.3
 Physical 25.3±9.4
 emotional 10.6±6.5
Notes: Data are presented as the mean ± standard deviation or number (%).
Abbreviations: ChF, chronic heart failure; ACeIs, angiotensin-converting enzyme 
inhibitors; ArBs, angiotensin II receptor blockers; nYhA, new York heart 
Association; lVeF, left ventricular ejection fraction; MlhFQ, Minnesota living with 
heart Failure questionnaire.
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Table 3 Clinical factors associated with health-related quality of lifea
Total  
MLHFQ score
P-value Physical  
MLHFQ score
P-value Emotional  
MLHFQ score
P-value
Duration of ChF 0.224 0.010 0.223 0.011 0.151 0.085
Previous MI
 Yes 52.0±19.0 0.373 25.5±10.3 0.684 11.2±6.2 0.418
 no 49.6±19.4 25.3±9.0 10.4±6.6
Previous AP
 Yes 51.6±19.0 0.325 25.8±9.9 0.344 10.8±6.6 0.796
 no 48.6±19.6 24.7±8.7 10.5±6.4
hypertension
 Yes 49.1±19.9 0.130 24.8±9.4 0.255 10.1±6.5 0.084
 no 54.0±17.1 26.9±9.5 12.2±6.4
Diabetes mellitus
 Yes 49.8±17.9 0.904 24.0±8.9 0.180 11.3±6.7 0.365
 no 50.6±19.9 25.9±9.6 10.3±6.4
number of comorbidities -0.053 0.538 -0.045 0.604 -0.039 0.649
nYhA class
 I or II 39.3±18.2 ,0.001 19.3±9.8 ,0.001 8.5±5.5 0.023
 III or IV 54.7±18.0 27.7±8.2 11.5±6.6
lVeF (%)
 $40 49.3±18.7 0.661 25.1±9.1 0.699 10.7±6.4 0.568
 ,40 51.5±19.9 25.5±9.9 10.4±6.6
Depressive symptoms
 Yes 57.9±17.6 ,0.001 28.5±8.9 ,0.001 13.1±6.4 ,0.001
 no 40.9±17.1 21.4±8.6 7.5±5.0
Cognitive impairment
 Yes 53.8±20.7 0.030 26.6±9.8 0.062 12.1±7.2 0.022
 no 46.7±17.0 24.0±8.9 9.1±5.2
length of hospital stay 0.198 0.021 0.162 0.060 0.199 0.020
Notes: aUnivariate analysis. hrQOl was assessed using the Minnesota living with heart Failure questionnaire; higher scores represent more impaired hrQOl. Data are 
presented as the mean ± standard deviation, Pearson’s product-moment correlation coefficient, or Spearman’s rank correlation coefficient.
Abbreviations: MlhFQ, Minnesota living with heart Failure questionnaire; ChF, chronic heart failure; MI, myocardial infarction; AP, angina pectoris; nYhA, new York 
heart Association; lVeF, left ventricular ejection fraction; hrQOl, health-related quality of life.
Table 2 Demographic factors associated with health-related quality of lifea
Total  
MLHFQ score
P-value Physical  
MLHFQ score
P-value Emotional  
MLHFQ score
P-value
Age -0.070 0.420 -0.043 0.620 0.024 0.777
gender
 Male 48.6±19.7 0.227 24.0±9.8 0.075 10.1±6.0 0.264
 Female 52.3±18.7 26.9±8.8 11.3±7.0
Marital status
 Married 50.9±20.4 0.810 25.1±9.6 0.810 10.4±6.4 0.824
 Unmarried 50.1±18.8 25.5±9.4 10.8±6.6
education -0.135 0.118 -0.179 0.038 -0.142 0.102
number of household members 0.121 0.161 0.081 0.347 0.181 0.035
household income -0.252 0.013 -0.254 0.012 -0.057 0.576
Notes: aUnivariate analysis. hrQOl was assessed using the MlhFQ; higher scores represent more impaired hrQOl. Data are presented as the mean ± standard deviation, 
Pearson’s product-moment correlation coefficient, or Spearman’s rank correlation coefficient.
Abbreviations: MlhFQ, Minnesota living with heart Failure questionnaire; hrQOl, health-related quality of life.
number of patients involved (2.2%). We found an inverse 
correlation between the number of drugs that patients were 
taking and HRQOL (P=0.047).
Independent predictors of HRQOL are shown in 
Table 5. Multiple linear regression analysis showed that the 
 presence of depressive symptoms (Sβ=0.407; P,0.001), 
higher NYHA class (Sβ=0.229; P=0.021), lower income 
(Sβ=-0.206; P=0.029), and longer duration of heart failure 
(Sβ=0.179; P=0.049) were independent predictors of poorer 
HRQOL.
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Table 4 Current medications associated with health-related quality of lifea
Total  
MLHFQ score
P-value Physical  
MLHFQ score
P-value Emotional  
MLHFQ score
P-value
Diuretics
 Yes 51.1±19.4 0.060 25.6±9.4 0.109 10.8±6.6 0.496
 no 38.4±13.9 20.6±8.9 8.9±4.1
Aldosterone antagonists
 Yes 53.7±20.2 0.046 26.9±9.3 0.048 11.4±7.0 0.231
 no 47.2±17.9 23.8±9.3 9.9±6.0
ACeIs
 Yes 50.8±20.2 0.731 25.0±9.5 0.443 11.1±6.7 0.230
 no 49.0±16.2 26.4±9.3 9.2±5.6
Beta-blockers
 Yes 49.6±21.4 0.555 24.4±10.0 0.272 10.9±7.0 0.709
 no 51.2±17.0 26.3±8.7 10.4±5.9
Digoxin
 Yes 54.5±17.8 0.049 27.2±9.0 0.128 12.1±6.8 0.115
 no 48.6±19.7 24.6±9.5 10.0±6.3
Anticoagulants
 Yes 49.6±19.0 0.681 24.3±8.8 0.219 10.5±6.6 0.751
 no 50.8±19.5 26.0±9.8 10.7±6.4
number of drugs 0.170 0.047 0.146 0.090 0.119 0.168
Notes: aUnivariate analysis. hrQOl was assessed using the Minnesota living with heart Failure questionnaire; higher scores represent more impaired hrQOl. Data are 
presented as the mean ± standard deviation or Spearman’s rank correlation coefficient.
Abbreviations: MlhFQ, Minnesota living with heart Failure questionnaire; ACeIs, angiotensin-converting enzyme inhibitors; hrQOl, health-related quality of life.
Table 5 Independent predictors of health-related quality of lifea
Sβ P-value
Depressive symptoms 0.407 ,0.001
nYhA class 0.229 0.021
Duration of ChF 0.179 0.049
Digoxin 0.139 0.125
Income -0.206 0.029
length of hospital stay 0.105 0.240
Diuretics -0.039 0.682
Cognitive impairment 0.005 0.959
Aldosterone antagonists -0.023 0.811
number of drugs 0.027 0.784
Notes: aMultiple linear regression analysis. R2=0.402; R2 (adjusted) =0.330. hrQOl 
was assessed using the Minnesota living with heart Failure questionnaire.
Abbreviations: hrQOl, health-related quality of life; nYhA, new York heart 
Association; Sβ, standard partial regression coefficient; CHF, chronic heart failure; 
R2, coefficient of determination.
Discussion
To our knowledge, this study is the first to assess determinants 
of HRQOL in elderly patients with heart failure in  Serbia, and 
one of only few that have examined HRQOL in the hospital 
setting.12,22–26 We used MLHFQ to evaluate HRQOL in our 
subjects. The mean MLHFQ score in our patients was higher 
than values reported by the majority of other studies, indicat-
ing poorer HRQOL in our study population.5,10,11,24 Reasons 
for this finding lie in the fact that more than two thirds of 
our subjects were in NYHA class III or IV, as well as in the 
negative impact of hospitalization on HRQOL.33
Our patients were older than the subjects included in most 
previous studies.3,5,6,11–14 We found no correlation between 
age and HRQOL, which is in accordance with the findings 
of Kato et al5 and Westlake et al.6 Other authors have found 
either a positive3,13 or a negative association between age and 
HRQOL.10,11 We did not observe sex differences in MLFHQ 
score, which is consistent with the findings of Heo et al,3 while 
other studies have reported worse HRQOL in women.5,9–11,13 
Marital status had no influence on HRQOL in our subjects, 
which is similar to the findings reported by Kato et al5 and 
Westlake and al,6 and different from the results published by 
Luttik et al, who found better HRQOL in married subjects.34 
The education level of our patients correlated negatively only 
with physical MLHFQ score, but not with total or emotional 
score, suggesting that more highly educated subjects have a 
better physical HRQOL dimension. This is in accordance with 
the findings of  Barbareschi et al, who reported better physi-
cal HRQOL in more highly educated patients.35 We found 
no association between number of household members and 
total or physical MLHFQ score, which is similar to the results 
of Kato et al5 but different from the findings of Luttik et al, 
who reported poorer HRQOL in patients living alone.34 Our 
study shows an inverse correlation between number of family 
members and the emotional dimension of HRQOL, which is 
in contrast with the findings of Franzen et al, who reported 
a similar emotional dimension of HRQOL in patients living 
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alone and those living with  family.10 Our findings indicate that 
a higher household income is associated with better overall 
HRQOL and its physical but not emotional dimension, so cor-
respond partially with the results of Clark et al, who observed 
better physical and emotional domains of HRQOL in subjects 
with higher income.36
The average length of CHF prior to study enrolment was 
a little more than 5 years, which is similar to the findings of 
Allen et al12 and longer than indicated by other authors.5 We 
found an inverse correlation between duration of CHF and 
HRQOL and its physical domain, which is consistent with 
the results published by Allen et al12 and differs from those 
of Kato et al, who found no significant relationship between 
length of CHF and HRQOL.5
In our study, a history of prior myocardial infarction, 
angina, hypertension, and diabetes was not associated with 
worse HRQOL. Previous studies have demonstrated that 
CHF of ischemic etiology is not associated with worse 
HRQOL,5,11 a finding consistent with ours, while Lewis et al 
found poorer HRQOL in CHF patients with angina.13 Data 
from the literature do not suggest a relationship between 
hypertension and HRQOL in CHF, which is in accordance 
with our results.10,11 Franzen et al10 found poorer HRQOL in 
patients with diabetes and CHF, while Kato et al5 did not find 
any such association, the latter finding being similar to our 
results. Our study did not find any correlation between num-
ber of comorbidities and MLHFQ scores, which is different 
from the results of Gott et al, who reported poorer HRQOL 
in subjects with two or more coexisting diseases.9
This study shows that patients with higher NYHA class had 
worse HRQOL, including its physical and emotional domains, 
which is consistent with the results of previous studies.5,6,9,10,12,13 
This finding is not surprising, given that the NYHA classifica-
tion is based on symptoms of heart failure and the physical 
limitations of the disease as experienced by patients, and 
thereby reflects their HRQOL. We observed similar HRQOL 
in patients with preserved and reduced LVEF, which is in 
accordance with results published by others.5,11–13
Depressive symptoms were present in more than one half 
of our patients. Previous studies have reported diverse preva-
lences of depression in patients hospitalized with heart failure 
(35%–70%) because of the different patient selection criteria 
and diagnostic tools used.7 Our patients with depressive 
symptoms had worse HRQOL than nondepressive subjects, 
which is consistent with findings published by others.5,9,14 Data 
from the literature suggest that depression is associated with 
a greater number and over-reporting of symptoms in CHF 
patients, which is a possible mechanism for poor HRQOL in 
such patients.37 There is evidence that treatment of depression 
could improve HRQOL in CHF patients.37
More than half of our subjects had signs of cognitive 
impairment, which is similar to the finding reported by 
 Heckman et al.38 Our study indicates that cognitive impairment 
is related to poorer HRQOL, while Pressler et al did not find 
significant relationship between these variables.39  Possible 
reasons for reduced HRQOL in patients with cognitive impair-
ment might be poor adherence with medical therapy, frequent 
coexistence of depression, and different interpretation of 
symptoms in such a population.38–40 We suggest screening for 
cognitive impairment in elderly patients with CHF, because 
data in the literature indicate that optimizing therapy for heart 
failure could possibly improve cognitive function.38
Our study shows that a longer length of hospital stay is 
associated with worse overall HRQOL and its emotional 
domain. Although the impact of hospitalization on HRQOL 
in the elderly is known,33 previous studies have not assessed 
the influence of length of hospital stay on HRQOL in CHF 
patients. The possible influence of longer length of hospital 
stay on HRQOL could in fact be that prolonged hospitaliza-
tion may lead to functional decline, worsening of cognitive 
impairment, and increased risk of iatrogenic injury.33
Regarding medication, we found that patients receiving 
aldosterone antagonists and digoxin had worse HRQOL. Our 
results are consistent with those reported by Berry et al,8 who 
found worse HRQOL in CHF patients taking aldosterone 
antagonists, but different from those of other authors who found 
no association between use of digoxin and HRQOL.5,41
Previous studies have shown a beneficial effect of 
 angiotensin-converting enzyme inhibitors and angiotensin 
II receptor blockers on HRQOL and a trend towards better 
HRQOL in patients receiving beta-blockers, which was not 
confirmed in our study.15,42,43 We found an inverse correlation 
between the number of drugs that patients were taking and 
HRQOL. To the best of our knowledge, there are no previ-
ous papers published regarding this issue in CHF. However, 
polypharmacy in the elderly, and in patients with CHF, leads 
to unpredictable drug interactions and more frequent adverse 
effects, which might affect HRQOL.44,45 Bearing that in mind, 
we propose that clinicians should carefully review medication in 
patients with CHF and avoid potentially unnecessary therapy.
The results of multiple linear regression analysis in our 
study showed that the presence of depressive symptoms, 
higher NYHA class, lower income, and longer duration of 
heart failure were independent predictors of poor HRQOL, 
with depression being identified as probably the most 
 influential factor affecting HRQOL in elderly patients with 
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CHF. Considering the results obtained from this study and the 
previously published data, which point to depression as a com-
mon condition with a negative impact on HRQOL in patients 
with CHF, we propose that measuring HRQOL and screening 
for symptoms of depression in the elderly with CHF should 
be routine in everyday clinical practice in order to detect such 
patients and target them for appropriate intervention.
While previous studies have shown that cardiac resynchro-
nization therapy, along with certain disease management and 
educational programs, are the only interventions that improve 
HRQOL in patients with heart failure,46 results from studies 
performed in the elderly do not give us strong evidence of pos-
sible benefits from such interventions on HRQOL.17 Therefore, 
more research is needed in the future. Considering that elderly 
patients with CHF often have a complex profile characterized 
by depression, cognitive impairment, multiple comorbidi-
ties, and polypharmacy, we suggest that the design of future 
interventional studies on HRQOL in this population include 
comprehensive geriatric assessment and follow-up, which 
might improve HRQOL in this vulnerable population.
study limitations
This study has several limitations. First, it is a single-center 
study performed in hospitalized elderly patients in one coun-
try, so the findings may not be generalizable. Second, we used 
only one disease-specific instrument to measure HRQOL (ie, 
the MLHFQ). Complementary use of other instruments, such 
as a generic HRQOL questionnaire (the Medical  Outcomes 
Study Short-Form 36) or the disease-specific Kansas City 
Cardiomyopathy Questionnaire, would probably give us 
more insight into the HRQOL of our patients.47,48 Further, 
although the MLHFQ is one of the most recommended and 
commonly used questionnaires for measuring HRQOL in 
heart failure,49 it has been used in only a small number of 
studies in hospitalized patients in the past and its reliability 
and validity is not as tested in this population as it is in 
outpatients.23,24,50 With regard to questionnaires canvassing 
depression, we used only the five-item Geriatric  Depression 
Scale and not other well established and widely used 
instruments, such as the Beck Depression Inventory or the 
Medical Outcome Study-Depression questionnaire.51 Third, 
we did not compare the HRQOL of our subjects with that 
in younger heart failure patients or in the elderly without 
CHF. Finally, we did not perform subgroup analysis by type 
of heart failure (eg, diastolic versus systolic), although dia-
stolic dysfunction is a common finding in elderly patients 
with CHF.11 Instead, we compared subjects with preserved 
($40%) and reduced (,40%) LVEF.
Conclusion
Our study indicates that the presence of depressive symptoms, 
higher NYHA functional class, lower income, and longer dura-
tion of CHF are independent predictors of poor HRQOL in 
elderly patients hospitalized with CHF in  Serbia. Further, we 
have highlighted the association between multiple medication 
usage and poor HRQOL, as well as the negative impact of 
cognitive impairment on HRQOL. Therefore, certain measures 
should be implemented to identify such patients, especially 
those with depressive symptoms, and appropriate interventions 
should be taken in order to improve their HRQOL.
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